Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals Inc (RXRX) is expecting -8.44% growth in the next quarter: What can investors do to maximize their returns?

Steve Mayer

A new trading day began on Friday, with Recursion Pharmaceuticals Inc (NASDAQ: RXRX) stock price down -7.86% from the previous ...

Recursion Pharmaceuticals Inc (RXRX) last year’s performance of -21.30% is a clear signal for an entertaining trading season.

Zack King

On Friday, Recursion Pharmaceuticals Inc (NASDAQ: RXRX) was -9.98% drop from the session before settling in for the closing price ...

Recursion Pharmaceuticals Inc (RXRX) volume exceeds 48.81 million: A new investment opportunity for investors

Sana Meer

A new trading day began on Friday, with Recursion Pharmaceuticals Inc (NASDAQ: RXRX) stock price down -0.54% from the previous ...

A look at Recursion Pharmaceuticals Inc’s (RXRX) recent performance gives investors their first glimpse of hope.

Steve Mayer

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) kicked off on Friday, up 1.94% from the previous trading day, before settling in for ...

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.